May 29, 2015

Stem cells collected during the process of umbilical cord blood banking after a mother’s stages of pregnancy are currently being used to treat more than 80 diseases, including many types of cancer and anemia treatment. With stem cell research continually expanding, new treatments are being discovered on a regular basis, which is why you should consider cord blood banking during your pregnancy stages if you are an expecting mother.

One of the ways that malignant cancer can be effectively treated is through adoptive immunotherapy that utilizes cytokine-induced killer (CIK) cells. Other types of CIK cells are those which are derived from umbilical cord blood. These cord blood cells (CB-CIK cells) have been studied both in vitro and in vivo, as studies assess the safety of administering CB-CIK cells to cancer patients.

In one study*, 15 patients with malignant cancer received CB-CIK cells, which means they benefited from the decision a mother-to-be made during her stages of pregnancy to collect and store her child’s umbilical cord blood, which was most likely donated to a public cord blood bank. (a service which CariCord offers.) The study concluded with many of the patients showing signs of great improvement, including full and partial remissions.

The results of this study are great news for the umbilical cord blood banking field, as well as cancer patients. Stem cell research now shows that it is safe to treat malignant cancer with CB-CIK cells, which were produced from cord blood an expecting mother made the decision to bank during her pregnancy stages. This is especially good news for cancer patients in poor health, as well as older patients who cannot withstand repeated blood collections, as an alternative treatment method utilizing cord blood is available and has shown to be a safe and effective way to treat cancer. Cord blood can also be used for anemia treatment as well, which is why expecting mothers should consider storing it through CariCord during their stages of pregnancy.

*CytoTherapy - Efficacy and safety of cord blood–derived cytokine-induced killer cells in treatment of patients with malignancies,  Published Online: May 09, 2015

FaceBook  Twitter